1.0Myanmar News Gazettehttps://myanmarnewsgazette.comadminhttps://myanmarnewsgazette.com/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="lQsyhntqPi"><a href="https://myanmarnewsgazette.com/first-in-class-broad-spectrum-nasal-spray-to-prevent-covid-19-and-other-common-respiratory-illnesses-set-to-begin-phase-2-trials/">First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://myanmarnewsgazette.com/first-in-class-broad-spectrum-nasal-spray-to-prevent-covid-19-and-other-common-respiratory-illnesses-set-to-begin-phase-2-trials/embed/#?secret=lQsyhntqPi" width="600" height="338" title="“First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials” — Myanmar News Gazette" data-secret="lQsyhntqPi" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> — ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO for influenza challenge study to assess the efficacy of fast-acting nasal spray designed to boost innate immunity SYDNEY, Australia, Sept. 28, 2021 (GLOBE NEWSWIRE) — ENA Respiratory, a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 […]https://ci3.googleusercontent.com/proxy/JXVBwP5YW-ih-WzwAgtf7nVp2ZOBrYlKbkIMliEv3huU80E3g2XjRJiRsBJxNrpDZOGZKIuRxtyhWjvsneKWvKNE2FAh_YyWCiBAGVzihCsoydgzC2qTTJfpYDRL6DM-sfgzUQ=s0-d-e1-ft#https://www.globenewswire.com/newsroom/ti?nf=ODMzMzE5MSM0NDI1NzY2IzUwMDA4MTA2OA==